Van Steenbergen W, Vanstapel M J, Desmet V, Van Kerckvoorde L, De Keyzer R, Brijs R, Fevery J, De Groote J
J Hepatol. 1985;1(4):359-68. doi: 10.1016/s0168-8278(85)80773-x.
Cimetidine-induced liver injury has only very rarely been reported. Three patients are described who developed signs of hepatic damage after the institution of cimetidine therapy. Transient signs of acute liver failure were noticed in one patient. Histologically, a cytotoxic type of injury with centrilobular confluent and bridging portal-central necrosis, accompanied by a mixed mono- and polymorphonuclear infiltrate with signs of cholangiolitis in the portal tracts was observed in two patients, whereas a hepatocanalicular type of cholestatic hepatitis was noticed in another patient. It is proposed that the mechanism of cimetidine-induced liver injury may vary in different patients: it may be due either to a 'metabolic idiosyncrasy' because of the production of hitherto unknown toxic metabolites or to a hypersensitivity reaction.
西咪替丁引起的肝损伤仅有极少的报道。本文描述了3例患者,他们在接受西咪替丁治疗后出现了肝损伤的迹象。1例患者出现了急性肝衰竭的短暂症状。组织学上,2例患者观察到细胞毒性损伤类型,伴有小叶中心融合和桥接门静脉-中央坏死,同时伴有混合性单核和多形核浸润以及门静脉区胆管炎迹象;而另1例患者则表现为肝小管型胆汁淤积性肝炎。有人提出,西咪替丁引起肝损伤的机制在不同患者中可能有所不同:可能是由于产生了迄今未知的有毒代谢产物导致的“代谢特异反应”,或者是一种超敏反应。